Obinutuzumab Showed Significantly Positive Results in Published Phase III Lupus Nephritis Study
Exciting breaking news: A paper published in the highly prestigious journal New England Journal of Medicine and presented at...
Search Results
You searched for: lupus nephritis
Results found: 1120
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
December 17, 2019
The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive...
Identifying Genetic and Immunological Determinants of Childhood Lupus Nephritis
This grant was awarded to an exceptional multidisciplinary research team of experts in immunology, pediatric rheumatology and nephrology, genetics...
How Are the New Lupus Nephritis Guidelines Impacting Treatment?
Perspective by renowned nephrologist Dr. Brad Rovin Recognized as National Kidney Month, March is the ideal time to learn more...
Less Risk and Greater Efficacy in Pediatric Lupus Nephritis Treatment
November 3, 2020
There is no doubt about it. The research into the mechanisms of pediatric lupus nephritis conducted by...
Iguratimod as an Alternative Therapy for Resistant Lupus Nephritis
April 1, 2020
An investigational treatment, iguratimod showed positive results in an early clinical study of people with lupus nephritis...
LRA Uncovering What Causes Lupus Nephritis to Improve Treatment
January 16, 2020
The Lupus Research Alliance has invested millions in research to get us to the point we’re at...
Low-Dose Chemotherapy May Help Lupus Nephritis
February 22, 2021
In a recent study published in Arthritis & Rheumatology, LRA-funded researcher Dr. Xian Zhang found that a...
People with Lupus and Especially Lupus Nephritis at Higher Risk for Heart Disease, Study Shows
March 17, 2021
People with systemic lupus erythematosus (SLE) are at risk for cardiovascular diseases, and those with lupus nephritis...
LRA Statement: Potential Lupus Nephritis Drug Voclosporin Granted Priority Review by the U.S. FDA
NEW YORK, NY. July 22, 2020. The Lupus Research Alliance congratulates Aurinia Pharmaceuticals Inc. on acceptance of its NDA...
ACR Released a Summary of the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis
The American College of Rheumatology (ACR) released a summary of the 2024 ACR Guideline for the Screening, Treatment, and...
Good News from Aurinia Pharmaceuticals for Lupus Nephritis
September 25, 2018
Congratulations to Aurinia Pharmaceuticals for completing patient enrollment in the AURORA Phase 3 clinical trial ahead of...